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miR-103 promotes endothelial maladaptation by
targeting lncWDR59
Lucia Natarelli1, Claudia Geißler1, Gergely Csaba2, Yuanyuan Wei1, Mengyu Zhu1, Andrea di Francesco1,3,
Petra Hartmann1, Ralf Zimmer 2 & Andreas Schober 1,4,5
Blood ﬂow at arterial bifurcations and curvatures is naturally disturbed. Endothelial cells
(ECs) fail to adapt to disturbed ﬂow, which transcriptionally direct ECs toward a maladapted
phenotype, characterized by chronic regeneration of injured ECs. MicroRNAs (miRNAs) can
regulate EC maladaptation through targeting of protein-coding RNAs. However, long non-
coding RNAs (lncRNAs), known epigenetic regulators of biological processes, can also be
miRNA targets, but their contribution on EC maladaptation is unclear. Here we show that
hyperlipidemia- and oxLDL-induced upregulation of miR-103 inhibits EC proliferation and
promotes endothelial DNA damage through targeting of novel lncWDR59. MiR-103 impedes
lncWDR59 interaction with Notch1-inhibitor Numb, therefore affecting Notch1-induced EC
proliferation. Moreover, miR-103 increases the susceptibility of proliferating ECs to oxLDL-
induced mitotic aberrations, characterized by an increased micronucleic formation and DNA
damage accumulation, by affecting Notch1-related β-catenin co-activation. Collectively, these
data indicate that miR-103 programs ECs toward a maladapted phenotype through targeting
of lncWDR59, which may promote atherosclerosis.
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Arterial endothelial cells (ECs) are exposed to differenttypes of blood ﬂow patterns and shear stresses, whichdetermine the endothelial phenotype. Indeed, laminar
ﬂow results in high shear stress and favors a quiescent EC phe-
notype characterized by a low proliferation rate and a reduced
inﬂammatory activation1,2. In contrast, disturbed ﬂow at arterial
branching points and curvatures constantly induces low-grade
injury to ECs resulting in apoptosis and inﬂammation3–5.
Moreover, the injury triggers a repair process by EC proliferation,
which is essential to maintain the endothelial lining5,6;
however, because disturbed ﬂow-induced EC injury is physiolo-
gic, endothelial repair remains ineffective6,7. Hence, EC mala-
daptation generates the Achilles heel of the arterial system,
vulnerable to additional damages by hyperlipidemia, which
inhibits EC proliferation8,9 and sustains chronic endothelial
wound healing9,10.
Different types of shear stresses regulate the expression of
speciﬁc microRNAs (miRNAs), which play key roles in EC injury
and proliferation by negatively regulating post-transcriptional
gene expression11. Indeed, endothelial Dicer affects inﬂammation
and promotes atherosclerosis partly by miR-103-mediated sup-
pression of Krüppel-like factor-4 (Klf4)12, which control the
phenotypic adaptation of ECs to mechanical stress. In addition,
miRNAs also affects EC proliferation. Indeed, miR-126-5p
decreases atherosclerosis and improve endothelial proliferation
by targeting Notch1-inhibitor Dlk16. MiRNAs can also interact
with long non-coding RNAs (lncRNAs), which have a broad
spectrum of action as epigenetic regulators13,14 and scaffold
molecules15, to promote angiogenesis and cell differentiation.
Among these, lincRNA-p2116, ANRIL15 and MALAT116 emerged
as miRNA decoys during atherosclerosis. However, the role of
lncRNAs as targets of miRNA on EC maladaptation is still
unclear.
We found that downregulation of miRNAs after Dicer
knockout in ECs increases the expression of lncRNA transcripts,
including the novel lncRNA WD Repeated Domain 59
(lncWDR59). In particular, targeting of lncWDR59 by miR-103
affects EC proliferation due to reduced Notch1 activation.
Moreover, Notch1 activity on EC proliferation is limited by
lncWDR59 through β-catenin, which prevents oxidized low-
density lipoprotein (oxLDL)-induced micronucleic DNA damage
accumulation in proliferating cells. Hence, miRNAs might pro-
mote EC maladaptation by negatively regulating lncRNA tran-
scripts, which can reprogram ECs toward a more adaptive
phenotype.
Results
Dicer regulates lncRNA expression in ECs during athero-
sclerosis. After a 12-week high fat diet (HFD) feeding period, the
expression of 172 out of 2926 lncRNAs was differentially regu-
lated in atherosclerotic arteries from EC-Dicerﬂox mice compared
with EC-DicerWT mice (fold change (FC) ≥ 1.5, P < 0.05, n= 2
mice per group) as determined by genome-wide microarray
analysis (Fig. 1a). Among the differentially regulated lncRNAs,
the expression of 97 and of 75 lncRNAs was increased and
decreased, respectively, in EC-Dicerﬂox mice (Fig. 1a). Among the
97 upregulated lncRNAs, 6 were downregulated while 5 were also
upregulated in the atherosclerotic arteries from Apoe−/− mice
after Dicer knockout in myeloid cells (Supplementary Table 2).
For 39 upregulated lncRNAs, including Jpx, Dlx1as, and Six3os,
which play a role in cell viability17 and differentiation18, the
transcript sequence was previously determined (Supplementary
Table 2). To determine the sequences of the other 58 upregulated
lncRNAs, including the novel most signiﬁcantly upregulated
lncRNA lncWDR59, we performed a strand-speciﬁc RNA
sequencing (RNA-seq) of the RNA isolated from murine aortic
ECs (MAoECs). In addition to 15,199 protein-coding genes
(fragments per kilobase million (FPKM) > 1), like the endothelial-
speciﬁc genes Cdh5, Nos3, and Pecam1 (Supplementary Fig-
ure 1A, B), we found that 34,524 lncRNA genes, including 18,478
annotated lncRNAs such as Malat1, Neat1, and Fendrr, and
16,046 novel lncRNA genes were expressed in MAoECs (Sup-
plementary Figure 1A,B). All 39 annotated lncRNAs upregulated
in EC-Dicerﬂox mice were also expressed in MAoECs (Supple-
mentary Table 2). In addition, read fragments of 5 out of the 58
non-annotated lncRNAs upregulated in EC-Dicerﬂox mice,
including lncWDR59, were identiﬁed by de novo transcript
assembly combined with chromatin-state maps19,20 (Supple-
mentary Figure 1C–E and Fig. 1c). Among these ﬁve lncRNAs,
the sequence of one new lncRNA, here called Leonardo, was fully
determined by RNA-seq (Fig. 1c, Supplementary Figure 1D and
Supplementary Notes). Leonardo gene is 1.317 kb long, consists of
5 exons and 4 introns, and is located between Gm29666 and
nucleoporin 50 (Nup50) genes on the negative strand of chro-
mosome 15. Analysis of the read fragments showed that the
Leonardo transcript is spliced into a 792 bp-long mature lncRNA,
which is predicted to fold into a thermodynamically stable sec-
ondary structure (Fig. 1c and Supplementary Figure 2). In con-
trast to Leonardo, the sequence of lncWDR59 was only partially
determined by RNA-seq. To discover the lncWDR59 full
sequence, we performed a modiﬁed RACE-PCR (rapid ampliﬁ-
cation of cDNA ends–polymerase chain reaction) (Supplemen-
tary Figure 1E and Supplementary Notes). The lncWDR59
transcript was 1.61 kb long, derived from one exon located on
chromosome 8 between the fatty acid 2-hydroxylase (fa2h) and
the wdr59 genes (Fig. 1c and Supplementary Figure 1E). Similarly
as Leonardo, lncWDR59 transcript showed a thermodynamically
stable secondary structure with characteristic functional lncRNA
loops (Supplementary Figure 2 and Supplementary Table 3).
Moreover, Coding Protein Calculator analysis showed a low
protein-coding ability for lncWDR59, similar to Malat1 (used as
positive control).
Let-7b and miR-103 target lncRNAs. Dicer knockout in ECs
reduces the expression of 20 miRNAs, including miR-103 and let-
7b, in atherosclerotic arteries12. To study whether miRNAs target
lncRNAs in ECs during atherosclerosis, the sequences of 44
lncRNAs upregulated in EC-Dicerﬂox mice were analyzed for
putative binding sites (BSs) for the 20 miRNAs downregulated
after Dicer knockout. A total of 189 BSs were predicted in 36
lncRNAs (Fig. 1d and Supplementary Figure 3). The highest
number of BSs was found for miR-103 (22 BSs in 21 lncRNAs)
and let-7b (22 BSs in 16 lncRNAs) in the sequence of 28
lncRNAs, including 9 lncRNAs that contain BSs for both miR-
NAs (Fig. 1d and Supplementary Figure 3). These data suggest
that miR-103 and let-7b play a prominent role in targeting
endothelial lncRNAs. The expression of 15 out of 28 lncRNAs
with a number of high-quantity BSs for miR-103 and let-7b was
studied in EC-Dicerﬂox mice and EC-DicerWT by quantitative
PCR (qPCR). Upregulation of 10 lncRNAs, including lncWDR59,
Leonardo, and lnc039159, in atherosclerotic arteries from EC-
Dicer knockout mice was conﬁrmed by qPCR (n= 4–7 mice per
group). By contrast, the other 5 lncRNAs and Malat1, which does
not contain miR-103 or let-7b BSs, were not differentially regu-
lated (Fig. 1e). To study whether loss of miR-103 and let-7b
mediates the upregulation of the 10 lncRNAs in ECs, MAoECs
were treated with Locked Nucleic Acid (LNA)-modiﬁed inhibi-
tors of miR-103 or let-7b. Treatment with let-7b inhibitors
increased Leonardo, Jpx, lnc064083, lnc039159, and lnc002669,
whereas lnc003783 and lnc052749 were not affected (Fig. 1f).
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Moreover, inhibition of miR-103 upregulated lncWDR59,
Gm4258, Jpx, lnc064083 and lnc039159, but not lnc002669 and
lnc073657 (Fig. 1f).
To assess whether let-7b and miR-103 target lncRNAs in the
RISC (RNA-induced silencing complex) of ECs, GW182
immunoprecipitation was performed in MAoECs treated with
let-7b or miR-103 mimics. Treatment with let-7b mimics
enriched the transcripts of Leonardo, lnc002669, and lnc039159
in the RISC, but not those of Jpx and lnc064083 (Fig. 1g). MiR-
103 mimics enriched lncWDR59, Gm4258, lnc064083, and Jpx
transcripts in the RISC (Fig. 1g). These results indicate a
prominent role of miR-103 in the targeting of lncRNAs in ECs.
miR-103 targets lncWDR59. Next, the effect of pro-atherogenic
conditions on the expression of the miR-103 targets lncWDR59,
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Gm4258, Jpx, and lnc064083 was studied in ECs and murine
arteries. In contrast to lnc064083, the expression of lncWDR59,
Jpx, and Gm4258 was higher in MAoECs than in bone marrow-
derived macrophages (BMDM) (Fig. 2a). Moreover, lncWDR59
levels were similar between ECs and murine aortic smooth
muscle cells (MAoSMCs), whereas miR-103 expression was
slightly lower in MAoECs than in ECs and BMDM (Supple-
mentary Figure 4A). Low shear stress, which increases endothelial
miR-103 expression21–25, reduced lncWDR59 and increased
lnc064083 compared to high shear stress, whereas Jpx and
Gm4258 expression was similar in MAoECs exposed to low or
high shear stress (Fig. 2b). Treatment of MAoECs with oxLDL,
(100 µg ml−1) upregulated miR-103 and decreased lncWDR59,
lnc064083, Gm4258, but not Jpx, and their expression was
restored by inhibition of miR-103 in oxLDL-treated ECs (Sup-
plementary Figure 4A, B and Fig. 2c). Notably, oxLDL treatment
did not affect lncWDR59 and miR-103 expression in BMDM and
MAoSMCs (Supplementary Figure 4A).
In mice, the expression of lncWDR59, Jpx, lnc064083, and
Gm4258 was substantially higher in athero-protected thoraco-
abdominal aortas than in athero-prone aortic arches (Fig. 2d), in
opposite to miR-103 expression (Supplementary Figure 4C).
Moreover, HFD feeding strongly downregulated lncWDR59,
lnc064083 and Gm4258 and upregulated miR-103 in the aorta
of Apoe–/– mice, whereas Jpx was not affected (Fig. 2e and
Supplementary Figure 4D). In addition, lncRNA expression was
studied in laser-microdissected ECs and macrophages from
atherosclerotic lesions from Apoe–/– mice (Supplementary
Figure 4E). LncWDR59 and Jpx expression was higher in ECs
than in macrophages, whereas the lnc064083 and Gm4258
expression levels were similar in both groups (Fig. 2f). In
opposite to the expression of miR-103, in situ hybridization
showed that lncWDR59 was more prominently expressed in ECs
from EC-Dicerﬂox mice than in those from EC-DicerWT mice
(Fig. 2g).
Taken together, these data show that, in contrast to Gm4258,
Jpx, and lnc064083, atherogenic conditions such as disturbed ﬂow
and hyperlipidemia consistently suppress lncWDR59 in ECs,
which is in opposite to the regulation of miR-103.
miR-103 affects EC proliferation by targeting lncWDR59. To
study the functional role of miR-103 and lncWDR59 interaction,
an antisense oligonucleotide (target site blocker (TSB)) was
designed to speciﬁcally block the binding of miR-103 to its
predicted lncWDR59 target site (Fig. 2h). Treatment of
MAoECs with TSB increased the expression of lncWDR59, but
not that of Jpx, Gm4258, lnc064083, or Klf4 (Fig. 2h). This result
conﬁrms the miR-103 target site located at nucleotides 1266–1291
of lncWDR59 transcript (Supplementary Figure 2).
MiR-103 promotes pro-inﬂammatory chemokine expression
by targeting KLF412. Although inhibition of miR-103 suppressed
Ccl2 and Cxcl1 in MAoECs, silencing lncWDR59 or treatment
with TSB did not affect the expression of these chemokines
(Fig. 3a and Supplementary Figure 4F). Moreover, treatment of
HFD-fed Apoe–/– mice with TSB that block the interaction
between miR-103 and Klf4 did not alter lncWDR59 expression
in arteries (Supplementary Figure 4G). Hence, lncWDR59
does not mediate the pro-inﬂammatory effects of miR-103 in
ECs.
In addition to endothelial inﬂammation, inhibition of EC
proliferation by hyperlipidemia at athero-prone sites promotes
atherosclerosis (Supplementary Figure 4H). Accordingly, athero-
protective EC-Dicer knockout restored endothelial proliferation
(Supplementary Figure 4I). In vitro, treatment of MAoECs with
miR-103 inhibitors or TSB increased EC proliferation and
reduced cyclin-dependent kinase inhibitor 1a (Cdkn1a) expres-
sion, whereas lncWDR59 inhibition reduced endothelial replica-
tion and upregulated Cdkn1a (Fig. 3b). LncWDR59 inhibition did
not alter the expression of Fa2h and Wdr59, indicating that
lncWDR59 and not its neighboring genes promotes EC
proliferation (Supplementary Figure 4J). Moreover, TSBs pro-
moted cell cycle progression of ECs from the G0 phase to the G1
and S+M phases (Supplementary Figure 4K) and increased
proliferation of ECs subjected to low shear stress, but not to high
shear stress (Fig. 3c). By contrast, TSB treatment did not affect
MAoSMC proliferation (Supplementary Figure 4L). Taken
together, these data show that miR-103 inhibits EC proliferation
and cell cycle progression by targeting lncWDR59, which may
enhance atherosclerosis.
Notch1 and β-catenin in lncWDR59-induced EC proliferation.
In addition to Klf4, genes related to Wnt and Notch signaling
pathways, which can increase cell proliferation26,27, were
most strongly regulated in atherosclerotic arteries from EC-
Dicerﬂox mice12. Accordingly, EC-Dicer knockout increased
endothelial Notch1 and β-catenin activation in atherosclerotic
arteries (Supplementary Figure 5A). Feeding a normal or
HFD increased and decreased endothelial Notch1 and β-catenin
activation and EC proliferation at predilection sites compared
to non-predilection sites (Supplementary Figure 5B-C). In vitro,
treatment with the Notch1-inhibitor DAPT or silencing
Ctnnb1 reduced EC proliferation (Fig. 3d and Supplementary
Fig. 1 LncRNAs upregulated in EC-Dicerﬂox mice during atherosclerosis and targets of let-7b and miR-103. a Pie graph from genome-wide microarray
analysis for lncRNA genes differentially expressed in the aortas of EC-Dicerﬂox mice compared with EC-DicerWT mice fed 12 weeks of HFD (n= 2 mice per
group). Not-regulated lncRNA genes are in green, and modulated lncRNAs are in gray. Among these, up- and downregulated lncRNAs with a P value cutoff
of 0.05 were divided according to their fold change. b Pie graph representing the 97 signiﬁcantly upregulated lncRNAs, following RNA-seq analysis from
MAoECs: 53 unknown lncRNAs (green), 5 lncRNAs for which the sequence was discovered by RNA-seq or RACE-PCR (blue), and 39 lncRNAs with a
sequence annotated in NONCODE or ENSEMBL databases (gray). Three out of 36 lncRNAs showed a known function (pink). c Gene locus and full
transcript sequence for 2 new lncRNAs, upregulated in EC-Dicerﬂox mice, i.e., Leonardo and lncWDR59. Detected regions for Leonardo (792 bp) and
lncWDR59 (1.61 kb) sequences derive from RNA-seq or RACE-PCR analysis, respectively. Probes from genome-wide microarray are reported in red. d
Cytoscape interaction network from RNAHybrid binding sites prediction between downregulated miRNAs and upregulated lncRNAs with a determined
sequence in EC-Dicerﬂox mice. LncRNA targets of let-7b or miR-103 are in light blue and red, respectively. LncRNAs with BS for both let-7b and miR-103 are
in orange. In gray are the rest of miRNAs target lncRNAs lacking a BS for miR-103 or let-7b. e, f The in vivo upregulation of lncRNAs with BS for let-7b and
miR-103 was conﬁrmed in EC-Dicerﬂox mice (n= 4–7 mice per group) (e) and in MAoECs after let-7b or miR-103 inhibition (f) by qPCR (n= 6 per group).
FC > 2. g Fold enrichment of lncRNA transcripts in the RISC complex after transfection of MAoECs with let-7b or miR-103 mimics together with a mutant
form of Ago2, following an immunoprecipitation (GW182-IP), measured by qPCR. Results of three independent experiments are shown. GAPDH and B2M
were used as housekeeping genes and relative expression analysis. FC fold change of control (ctrl) group. The data are represented as mean ± SEM of the
indicated number (n) of repeats. *P < 0.05, and **P < 0.01 by Student’s t-test
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Figure 5D,E), indicating that Notch1 and Wnt signaling promote
athero-protective EC regeneration.
Next, we studied whether Notch1 and β-catenin play a role in
lncWDR59-mediated EC proliferation. Inhibition of miR-103 and
TSB signiﬁcantly promoted whereas lncWDR59 knockdown
reduced the activation of Notch1 and β-catenin (Fig. 3e, f).
TSB-induced EC proliferation was prevented by DAPT, indicat-
ing that Notch activation acts downstream of lncWDR59 on
endothelial proliferation (Fig. 3g). Surprisingly, silencing Ctnnb1
enhanced the proliferation of TSB-treated ECs (Fig. 3g).
Moreover, DAPT reduced the proliferation of ECs treated with
siCtnnb1 and TSB, demonstrating that β-catenin can inhibit EC
proliferation by limiting Notch1 activation (Fig. 3h). Accordingly,
DAPT decreased β-catenin activation in ECs treated with or
without TSBs, whereas silencing Ctnnb1 reduced Notch1
activation (Notch intracellular domain (NICD)) in control-
treated ECs (Fig. 3i, j). Moreover, silencing Ctnnb1 increased
Notch1 activation in TSB-treated ECs (Fig. 3i, j). These data
show that the interaction between miR-103 and lncWDR59
inhibits EC proliferation due to reduced lncWDR59-mediated
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Fig. 2 Screening of miR-103 target lncRNAs expression and identiﬁcation of lncWDR59 as target of miR-103. qPCR for miR-103 target lncRNAs expression
in different cells or conditions, such as a MAoECs and BMDM (n= 3–5 per group), b MAoECs under high or low shear stress (HSS or LSS) conditions for
48 h (n= 3 per group), c MAoECs treated with oxidized LDL (oxLDL) for 24 h (n= 4 per group), d aortic arches (Arch) and thoraco-abdominal
(Thoracoabd) aortas from 12-week normal diet-fed Apoe−/− mice (n= 5–10 per group), e all aorta from Apoe−/−mice fed 12 weeks of normal diet (ND) or
high-fat diet (HFD) (n= 3–5 per group), and f ECs and plaques isolated from Apoe−/− mice fed 4 weeks an HFD using the laser microdissection system (n
= 3–7 per group). g In situ hybridization for miR-103 and lncWDR59 on 12 weeks HFD-fed EC-DicerWT and EC-Dicerﬂox mice. vWF and DAPI were used to
stain ECs and nuclei, respectively (n= 4 mice per group). h The 6-mer seed predicted binding site for miR-103 on lncWDR59 transcript predicted using
RNAHybrid and the sequence of the competitive TSB, which speciﬁcally inhibits the binding of miR-103 on lncWDR59 transcript (n= 3–8 per group). Non-
classical Watson and Crick interactions between A and U were represented with a dot. B2m was used as housekeeping gene for relative quantiﬁcation. EC
endothelial cells, MAoECs murine aortic ECs, BMDM bone marrow-derived macrophages, TSB target site blocker. Data are represented as mean ± SEM of
the indicated number (n) of repeats. *P < 0.05, **P < 0.01, and ***P < 0.001 by Student’s t-test. Scale bar: 25 µm
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Notch1 and β-catenin activation. Moreover, blocking miR-103-
mediated repression of lncWDR59 induced a negative feedback
loop in which β-catenin limited Notch1 activation and EC
proliferation.
lncWDR59 blocks Numb to promote Notch1 activation. To
study the mechanisms by which lncWDR59 regulates Notch1
activation, the subcellular localization of lncWDR59 was ana-
lyzed. Treatment of MAoECs with miR-103 inhibitors increased
the cytosolic levels of lncWDR59 (Fig. 4a), indicating that
lncWDR59 may bind to Notch1 or to cytosolic proteins related to
the Notch1 signaling pathway. Therefore, we determined the
interaction propensity between lncWDR59 and NICD, deltex4,
Numb, anterior pharynx-defective 1 (aph-1), presenilin-1 and -2
(psen-1 and -2), and nicastrin using the catRAPID prediction
software. LncWDR59 had no binding sites predictable in the
amino acid sequence of NICD. Accordingly, lncWDR59 was not
enriched in NICD-immunoprecitiated (IP) samples from
MAoECs treated with control LNAs or miR-103 inhibitors
(Fig. 4b and Supplementary Figure 6A), indicating that
lncWDR59 does not bind to NICD. Among the Notch1 pathway-
related proteins, Numb contained sites with the highest pro-
pensity to interact with lncWDR59, (Fig. 4c and Supplementary
Figure 1F). To study whether lncWDR59 binds to Numb, we
performed Numb-IP, which revealed that lncWDR59 was not
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Fig. 3 miR-103 target lncWDR59 regulates EC proliferation through Wnt and Notch1 signaling pathways. MAoECs were transfected for 24 h with miR-103
inhibitors (miR-103 inh), lncWDR59 Gapmers (GlncWDR59), or TSB (a) to check Ccl2 and Cxcl1 relative expression (n= 3–6 per group), or (b) to stain
with an anti-Ki67 antibody to analyze their proliferation and cdkn1a expression by qPCR (n= 4–8 per group). DAPI was used for nuclei staining. EC
proliferation was calculated as number of Ki67+ cells on total number of cells and expressed in percentage (n= 4 per group). c MAoECs were seeded in
ibidi ﬂow chamber slides and incubated with EdU and TSB or control LNAs. ECs were subjected for 48 h to low (LSS; 5.51 dyn cm−2) or high (HSS; 10 dyn
cm−2) shear stresses and stained for EdU-DNA incorporation (n= 3–4 per group). d MAoECs were treated with DAPT or siRNAs against β-catenin
(siCtnnb1) for 24 h and stained with anti-Ki67 antibody to analyze their proliferation as described before. DMSO and siRNA were used as controls of DAPT
and siCtnnb1, respectively (n= 4–8 per group). e, f MAoECs were transfected with miR-103 inhibitors, TSBs, or GlncWDR59 as described before and
stained with an anti-activated Notch1 (NICD) (e) or β-catenin antibody (f). Data were represented as number of nuclear NICD+, and nuclear (star) and
perinuclear (arrowheads) β-cat+ localization. Inhibition of β-catenin activation makes β-catenin visible only as membrane adaptor protein for cell-to-cell
intercellular adhesions. Data were normalized on total number of cells and expressed in percentage (n= 4–8 per group). g–jMAoECs were treated for 24 h
with DAPT or siCtnnb1, alone or in combination with TSB to analyze (g) EC proliferation by Ki67 staining. DMSO or siRNAs in combination with LNA-
controls were used as controls. Data were normalized on total number of cells and expressed in percentage (n= 4 per group). h Analysis of Ki67+ TSB
+siCtnnb-transfected MAoECs stimulated with DAPT or DMSO for 24 h (n= 4 per group). Analysis of β-catenin (i) or NICD (j) nuclear localization. The
graphs correspond to the analysis of nuclear (stars) and perinuclear (arrowheads) β-cat+ and nuclear NICD+ localization. Data were normalized on total
number of cells and expressed in percentage (n= 4–8 per group). Ccl2 C-C motif chemokine ligand 2, Cxcl1 C-X-C motif chemokine ligand 1, cdkn1a cyclin-
dependent kinase inhibitor 1a, TSB target site blockers, DMSO dimethyl sulfoxide, DAPT γ-secretase inhibitor. Data are represented as mean ± SEM of the
indicated number (n) of repeats. *P < 0.05, **P < 0.01, and ***P < 0.001 by one-way ANOVA and t-test. Scale bar: 25 µm
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enriched (Supplementary Figure 6B). However, NICD was high in
the Numb-IP fraction, whereas it was low in the input fraction
(Fig. 4d, e and Supplementary Figure 6C, D). To test the existence
of a possible competitive binding between lncWDR59 and NICD
to Numb, Numb-IP was performed in MAoECs after miR-103
inhibition. LncWDR59 was highly enriched in the Numb-IP
compared to the input fraction. In addition, miR-103 inhibition
reduced NICD levels in the Numb-IP fraction and increased
those in the input (Fig. 4d, e and Supplementary Figure 6B–D).
Interestingly, one of the four predicted Numb-interaction sites on
lncWDR59 transcript comprises miR-103 BS, and involves the
phosphotyrosine-binding domain of Numb, through which
Numb interacts and induces Notch1 degradation28. Hence, these
data suggest that binding of miR-103 on lncWDR59 prevents
a b
In
pu
t
NI
CD
Ig
G
IP
In
pu
t
NI
CD
Ig
G
IP
miR-103 inhCtrl LNA
lncWDR59
NICD
Input
Ctrl LNA miR-103 inhCt
rl 
LN
A
m
iR
-1
03
   
 in
h
IgG NICD IgG NICD
(80 kDa)
Nucleus Cytosol
0
2
4
6
8
*
0
20
40
60
80
100
120
(92 nt band)
ln
cW
D
R
59
re
la
tiv
e 
ex
pr
es
si
on
 (
F
C
)
C
tr
l L
N
A
m
iR
-1
03
 in
h
C
tr
l L
N
A
m
iR
-1
03
 in
h
C
tr
l L
N
A
m
iR
-1
03
 in
h
b2
m
 r
el
at
iv
e
R
N
A
 le
ve
ls
 (
%
 to
ta
l)
lncWDR59 (nt)
N
um
b 
(a
a)
0 200 400 600 800 1000
0
200
400
600
500
100
300
3
2
1
0
–3
–2
–1
4
–4
Interaction propensity = 210  
Discriminative power = 100%
c
e
d
103
104
105
106
0
1
10
100
In
pu
t
Nu
m
b
Ig
G
IP
In
pu
t
Nu
m
b
Ig
G
IP
miR-103 inhCtrl LNA
lncWDR59
Numb
NICD
Input Numb-IP
0
1
2
3
4
5
Ctrl LNA
miR-103 inh
*
* (80 kDa)
(80 kDa)
C
tr
l L
N
A
m
iR
-1
03
 in
h
ln
cW
D
R
59
fo
ld
 e
nr
ic
hm
en
t
Ig
G
N
IC
D
ab
so
lu
te
 q
ua
nt
ifi
ca
tio
n 
(×
10
4 )
Fig. 4 LncWDR59 interaction with Notch1-inhibitor Numb. a Nuclear and cytoplasmic lncWDR59 levels in MAoECs treated with miR-103 or control-LNA
inhibitors for 24 h. B2m was used as quality marker of nucleus and cytoplasmic RNA isolation (n= 3 per group), expressed as percentage of total b2m RNA
expression. Gapdh was used for relative quantiﬁcation. b LncWDR59 expression in MAoECs before (input) and after NICD-immunoprecipitation (IP)
analyzed by qPCR and loaded on 2% agarose gel (lncWDR59 amplicon of 92 bp). Efﬁciency of NICD-IP was tested by western blot (n= 3 per group). IgGs
were used as IP-negative controls. c Heat-maps representing the interaction propensity analysis between lncWDR59 and Numb. The y- and x-axes
represent the index of the protein and lncWDR59 sequences, respectively. The colors indicate the interaction score of individual nucleotide and amino acid
pairs (rank ± 4). The interaction strength with respect to a training set is represented by the interaction score and the discriminative power values. d, e
LncWDR59 expression in MAoECs treated with miR-103 or control-LNA inhibitors for 24 h analyzed by qPCR, following Numb-IP. Ampliﬁcation products
were loaded on 2% agarose gel (lncWDR59 amplicon of 92 bp), together with PCR products from lncWDR59 expression analyzed before IP (d). Numb-IP
efﬁciency was evaluated by western blot (d) and NICD binding to Numb quantiﬁed (n= 3 per group) (e). IgGs were used as IP-negative controls. FC fold
change of control-LNA inhibitors of the corresponded subcellular fraction, IP immunoprecipitate, NICD Notch intracellular domain, aa amino acid, nt
nucleotides. *P < 0.05 by Student’s t-test
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lncWDR59 and Numb interaction, allowing Numb interaction to
NICD.
lncWDR59 reduces oxLDL-induced DNA damage. EC pro-
liferation regenerates low shear stress-induced damage of ECs6.
However, additional injuries, for example oxLDL-induced DNA
damage29, may exhaust the EC repair capacity and enhance
atherosclerosis6. In line, treatment of MAoECs for 24 h with
oxLDL dose-dependently increased DNA damage and reduced
EC proliferation determined by immunostaining of
phosphorylated histone variant H2AX (γH2AX foci)30 and Ki67,
respectively (Fig. 5a). Moreover, we performed combined γH2AX
and CD31 immunostaining of en face prepared aortas from Apoe
−/− mice by image stack and three-dimensional (3D) recon-
struction microscopy to determine the effect of HFD on endo-
thelial DNA damage. Whereas endothelial DNA damage was not
different between predilection and non-predilection sites in ND-
fed mice, a 12-week HFD increased γH2AX in ECs at predilection
sites, but not at non-predilection sites of atherosclerosis (Fig. 5b).
This result indicates that low shear stress increases the
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Fig. 5 Role of lncWDR59 on hyperlipidemia-mediated DNA damage and MN formation in ECs. a Immunoﬂuorescence analysis of Ki67 or phosphorylated
gamma H2AX histone (γH2AX) in MAoECs treated for 24 h with 25 or 100 µg ml−1 oxLDL. Data are represented as percentage of total number of cells (n
= 4 per group). b The en face 3D reconstructed arch and thoracic aortae from Apoe−/− mice fed 12 weeks of ND or HFD and stained for γH2AX and CD31.
The graph represents the number of CD31+ cells with a positive γH2AX staining in the nucleus, normalized on total number of CD31+ cells and expressed
in percentage (n= 4 mice per group). c Analysis of nuclear γH2AX+ vWF+ in the root of EC-Dicerﬂox mice compared to EC-DicerWT mice, fed 12 weeks of
HFD, and expressed as percentage of total vWF+ cells (n= 3 mice per group). d Analysis of nuclear γH2AX+ MAoECs treated with TSBs for 24 h, and
stimulated with or without 25 µgml−1 oxLDL. Data are normalized on total number of ECs and expressed in percentage (n= 4–6 per group). e MAoECs
were treated for 24 h with DAPT or siCtnnb1 to analyze the nuclear γH2AX+ staining. The same treatments were performed in 25 µgml−1 oxLDL-treated
MAoECs, alone or in combination with TSB, to analyze the nuclear γH2AX+ staining. Data are normalized on total number of cells and expressed in
percentage (n= 3–5 per group). f Analysis of micronucleated CD31+ cells (MN cells) and CD31+ cells with γH2AX+micronuclei (γH2AX+MN) on en face
3D reconstructed arch and thoracic aortae from Apoe−/− mice fed 12 weeks of ND or HFD (n= 3 mice per group). g Analysis of MN formation and γH2AX
+MN from micronucleated MAoECs (γH2AX+MN) treated for 24 h with 25 or 100 µg ml−1 oxLDL (n= 3 per group). Micronucleated MAoECs treated or
not with 25 µg ml−1 oxLDL, captured using confocal microscope. Transversal section shows γH2AX staining around the heterochromatin of principal
nucleus and inside of the MN. h Analysis of MN formation and γH2AX+MN in micronulceated MAoECs treated with TSBs for 24 h, and stimulated with or
without 25 µg ml−1 oxLDL. Data are normalized on total number of ECs and expressed in percentage (n= 4–10 per group). i Analysis of MN formation and
γH2AX+ MN MAoECs treated for 24 h with DAPT or siCtnnb1, in combination with 25 µg ml−1 oxLDL (n= 3–10 per group). DMSO dimethyl sulfoxide,
DAPT γ-secretase inhibitor. Data are represented as mean ± SEM of the indicated number (n) of repeats. *P < 0.05, **P < 0.01, and ***P < 0.001 by
Student’s t-test. #P < 0.05 versus all other groups by one-way ANOVA and two-way ANOVA. Scale bar: 25 µm
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susceptibility of ECs to oxLDL-induced DNA damage. Hence,
hyperlipidemia may promote atherosclerosis by limiting EC
proliferation and by increasing endothelial DNA damage.
Notably, endothelial Dicer knockout reduced endothelial
γH2AX in hyperlipidemic Apoe−/− mice (Fig. 5c), indicating a
role of miRNAs in hyperlipidemia-induced endothelial DNA
damage. To study whether miR-103 affects endothelial oxLDL-
mediated DNA damage by targeting lncWDR59, γH2AX was
analyzed in MAoECs treated with TSBs and oxLDL. TSBs
reduced γH2AX in MAoECs treated with or without oxLDL
(Fig. 5d). Blocking Notch1 by DAPT or silencing Ctnnb1 abol-
ished the TSB-mediated reduction of γH2AX in oxLDL-treated
ECs (Fig. 5e). However, in the absence of TSB silencing, Ctnnb1
but not DAPT increased γH2AX in ECs treated with or without
oxLDL (Fig. 5e and Supplementary Figure 7A). Taken together,
these data indicate that the protective effect of lncWDR59 on
endothelial DNA damage is mediated by Notch1 and β-catenin
activation.
lncWDR59 reduces oxLDL-mediated micronuclei formation.
During proliferation the chance of mitotic errors is high and can
lead to the generation of extranuclear chromatin bodies, called
micronuclei (MN), where double-strand breaks accumulate31,32.
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Fig. 6 Role of Sox17 on β-catenin activation, MN formation, and micronuclear DNA damage. a qPCR analysis of Sox17 expression in MAoECs treated with
TSB, alone or in combination with100 µgml−1 oxLDL for 24 h (n= 4 per group). b qPCR analysis of Sox17 expression in MAoECs treated for 24 h with
DAPT or siCtnnb1, alone or in combination with TSB (n= 4 per group). B2m was used for relative quantiﬁcation. c, d Analysis of nuclear (stars) and
perinuclear (arrowheads) β-catenin, activated Notch intracellular domain (NICD) (c), or nuclear Ki67 staining (d) in MAoECs treated for 24 h with Sox17
gapmers, alone or in combination with TSB. Data are normalized on total number of cells and expressed in percentage (n= 4 per group). e, f Analysis of
γH2AX+ cells, MN formation, γH2AX+ MN from micronucleated cells (γH2AX+ MN) (e), and cdkn2a expression (f) in MAoECs treated for 24 h with
Sox17 gapmers, alone or in combination with TSB (n= 4–6 per group). B2m was used for relative quantiﬁcation. Data regarding MN formation are
normalized on total number of cells and expressed in percentage. Data regarding γH2AX+ MN are normalized on total number of micronucleated cells,
following normalization on total number of cells, and expressed in percentage. TSB target site blocker, DMSO dimethyl sulfoxide, DAPT γ-secretase
inhibitor, G Sox17 Sox17 gampers, cdkn2a cyclin-dependent kinase inhibitor 2a. *P < 0.05, **P < 0.01, and ***P < 0.001 by Student’s t-test. By two-way
ANOVA and one-way ANOVA. Scale bar: 25 µm
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05065-z ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2645 | DOI: 10.1038/s41467-018-05065-z | www.nature.com/naturecommunications 9
In line, the number of MN was high in proliferating ECs (Sup-
plementary Figure 7B).
Whereas damaged DNA is efﬁciently repaired in the nucleus,
persistent DNA damage in the MN may further impair
transcriptional activity in MN and compromise cell function32.
Because in vitro oxidative stress can induce MN in ECs,
we analyzed the effect of hyperlipidemia on MN formation in
ECs in arterial en face prepared aortas. In contrast to the
thoracic aorta, where MN-containing ECs were less than in the
aortic arch under ND, HFD feeding increased MN formation in
aortic arch ECs (Fig. 5f). Moreover, in ND-fed mice micronuclear
γH2AX in aortic arch ECs was more frequent than in thoracic
ECs (Fig. 5f). HFD feeding increased the micronuclear γH2AX in
aortic arch but not thoracic ECs (Fig. 5f). In vitro, oxLDL
increased MN formation and micronuclear γH2AX (Fig. 5g).
These data indicate that oxLDL induces MN formation and
micronuclear DNA damage in ECs at predilection sites of
atherosclerosis.
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Fig. 7 MiR-103/lncWDR59 conserved function in vivo during atherosclerosis. Apoe−/− mice were fed 12 weeks of HFD and were injected four times (once
per week) with TSBs or control-LNA oligonucleotides (0.5 mg per 20 g). Paxgene-ﬁxed/parafﬁn-embedded roots were sectioned and used for (a) elastic
van Gieson (EVG) staining, (b) Ki67, and (c) γH2AX immunoﬂuorescence staining. a EVG-stained aortic roots were used to quantify the plaque area per
valve, the necrotic core area (expressed as percentage of total plaque area), and the ﬁbrous cap thickness (n= 5 mice per group, 3–4 slides per mouse).
Scale bar: 200 µm. b,c The number of Ki67+/ and γH2AX+/vWF+ cells was divided to the total number of vWF+ cells and expressed as percentage (n= 5
mice per group, 3 slides per group). Ctrl control-LNA, TSB target site blockers. *P < 0.05 and **P < 0.01 by Student’s t-test. Scale bar: 25 µm
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Next, we studied the role of miR-103-mediated suppression of
lncWDR59 on oxLDL-induced MN formation in ECs. TSBs
abolished oxLDL-induced MN formation and micronuclear
γH2AX (Fig. 5h), an effect prevented by blocking Notch1 or
Ctnnb1 silencing (Fig. 5i). Moreover, in the absence of TSB,
silencing Ctnnb1 but not DAPT increased MN formation and
micronuclear γH2AX in EC treated with or without oxLDL
(Fig. 5i and Supplementary Figure 7C, D). Hence, these results
suggest that suppression of lncWDR59 by miR-103 in ECs
increases MN formation and micronuclear DNA damage in
response to oxLDL by inhibiting Notch1 and β-catenin. More-
over, hyperlipidemia may promote atherosusceptibility of pre-
dilection sites by DNA damage accumulation in the endothelial
MN.
Analysis of cyclin-dependent kinase inhibitor 2a (cdkn2a,
p16INK4A) expression showed that treatment of MAoECs with
TSB reduced Cdkn2a, whereas DAPT treatment or Ctnnb1
silencing increased and reduced Cdkn2a, respectively (Supple-
mentary Figure 7E). Moreover, DAPT treatment or Ctnnb1
silencing abolished and enhanced TSB-mediated effect on Cdkn2a
expression (Supplementary Figure 7E), suggesting that
lncWDR59 might protect ECs from DNA damage-associated
premature senescence8,33.
lncWDR59 activates β-catenin through Notch1-mediated
Sox17 expression. To determine the mechanism by which
lncWDR59 promotes Notch1-mediated β-catenin activation, we
studied genes related to the Wnt and Notch1 signaling pathways
differentially regulated in HFD-fed EC-Dicerﬂox mice12, such as
lymphoid enhancer binding factor 1 (Lef1), dickkopf WNT sig-
naling pathway inhibitor 2 (Dkk2), sex determining region Y-box
(Sox) 17 (Sox17), deltex E3 ubiquitin ligase 4 (Dtx4), Sox4, and
Numb (Supplementary Figure 7F). Inhibition of miR-103
increased Lef1, Dkk2, Sox17, and Dtx4 in MAoECs, but did not
affect Sox4 and Numb (Supplementary Figure 7F). LncWDR59
inhibition reduced Sox17, Dtx4, and Sox4 and increased Dkk2,
whereas Lef1 and Numb expression was unchanged (Supple-
mentary Figure 7F). Notably, TSBs increased Sox17 expression in
MAoECs treated with or without oxLDL, and prevented the
oxLDL-induced downregulation of Sox17 (Fig. 6a). Although
Sox17 expression was decreased by both DAPT and Ctnnb1
silencing, TSBs prevented only the effect of Ctnnb1 silencing on
Sox17 expression (Fig. 6b). Silencing Sox17 abolished the activa-
tion of β-catenin induced by TSB, whereas TSB-mediated Notch1
activation was slightly increased after silencing Sox17 (Fig. 6c).
Inhibition of Sox17 enhanced EC proliferation, cdkn2a expres-
sion, γH2AX, MN formation, and micronuclear γH2AX in TSB-
treated MAoECs (Fig. 6d-f). Taken together, these data indicate
that lncWDR59 promotes β-catenin activity by upregulating
Notch1-mediated Sox17 expression. Moreover, like β-catenin,
Sox17 limits EC proliferation and reduces micronucleic DNA
damage.
Targeting of lncWDR59 by miR-103 promotes atherosclerosis.
To assess the role of the interaction between miR-103 and
lncWDR59 in vivo, Apoe−/− mice were treated with lncWDR59-
TSBs or control LNA-modiﬁed oligonucleotides (0.5 mg per 20 g
per injection) during the last 4 weeks of a 12-week HFD feeding
program. Compared with mice treated with control LNAs,
treatment with lncWDR59-TSBs reduced atherosclerosis, the
necrotic core area, and endothelial DNA damage, and increased
EC proliferation (Fig. 7a–c), whereas the ﬁbrous cap thickness
and the Cxcl1-expressing ECs (Supplementary Figure 7H) were
not affected (Fig. 7a). Taken together, these data indicate that
miR-103 enhances atherosclerosis and impairs EC regeneration
partly by suppressing lncWDR59.
Conserved function of human lncWDR59 in ECs. In humans, a
homolog of lncWDR59 (hsa-lncWDR59) exists expressed from a
conserved genomic location between the FA2H and WDR59
genes on human chromosome 16 (Fig. 8a). MiR-103 mimics
enriched hsa-lncWDR59 in the GW182-IP fraction from human
aortic ECs (HAoECs) compared to control mimics (Fig. 8b).
Transfection of HAoECs with hsa-lncWDR59 inhibitors down-
regulated hsa-lncWDR59 expression (Supplementary Figure 7G),
reduced EC proliferation, and MN formation (Fig. 8c).
In human atherosclerotic lesions, in situ hybridization
indicated that endothelial expression of miR-103 and lncWDR59
was high and low, respectively, in human atherosclerotic lesions
compared with control vessels (Fig. 8d). Analysis of hsa-
lncWDR59 expression in human atherosclerotic lesions indicated
that hsa-lncWDR59 and SOX17 expression levels were negatively
correlated with necrotic core area and positively with endothelial
proliferation, whereas the levels of CDKN2A were correlated with
increased necrotic core area (Fig. 8e and Supplementary
Figure 7I). Moreover, the levels of hsa-lncWDR59 correlated
with increased SOX17 levels (Fig. 8e). Taken together, these data
indicate that hsa-lncWDR59 shows a conserved function in
human ECs and might also play an athero-protective role in
humans.
Discussion
Chronic, low-grade endothelial injury and regeneration is a
characteristic feature of endothelial maladaptation to disturbed
ﬂow at arterial bifurcations. We found that miR-103 inhibits
endothelial proliferation by targeting lncWDR59, which resulted
in reduced activation of Notch1 signaling. Moreover, suppression
of lncWDR59 by miR-103 increased the susceptibility of pro-
liferating ECs to oxLDL-mediated DNA damage and mitotic
errors by reducing Notch1-mediated β-catenin activation. Hence,
miR-103-mediated suppression of lncWDR59 promotes endo-
thelial maladaptation by impairing EC regeneration and
increasing mitotic aberrations during hyperlipidemia (Supple-
mentary Figure 8).
Endothelial Dicer promotes arterial susceptibility to athero-
sclerosis by generating miRNAs9,10,12. In addition to mRNAs,
miRNAs can interact with other RNA species, like lncRNA
transcripts. This interaction can inhibit miRNA function, because
lncRNAs can act as molecular decoys or sponges of miRNAs34,35
or mediate the silencing of lncRNAs36,37. Our data show that
Dicer suppressed the expression of multiple lncRNAs in ECs,
indicating that targeting of lncRNAs by miRNAs plays a role in
EC maladaptation. The miRNAs miR-103 and let-7b silenced
lncRNAs, such as the novel intergenic lncRNAs lncWDR59 and
Leonardo, respectively, which contain mainly non-canonical
miRNA binding sites. We conﬁrmed that miR-103 targets
lncWDR59, which was downregulated at predilection sites and by
hyperlipidemia, via a 6-mer binding site in ECs. Whereas miR-
103 promotes endothelial inﬂammation by silencing KLF412, the
interaction between miR-103 and lncWDR59 in ECs inhibited
cell proliferation and, in response to oxLDL, increased micro-
nucleic DNA damage. Hence, miR-103 might promote an EC
maladaptive phenotype by the synergistic silencing of Klf4 and
lncWDR59. In line, our data indicate that lncWDR59 limits the
increased susceptibility of proliferating ECs to oxLDL-induced
DNA damage and micronuclei formation. Moreover, miR-103-
induced silencing of lncWDR59 may mediate the effect of
endothelial Dicer on disturbed ﬂow-induced EC proliferation and
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Fig. 8 Human lncWDR59 conserved role in vitro and in human plaques. a Gene locus and full transcript of human lncWDR59 (hsa-lncWDR59) sequence
on chromosome 16 between FA2H and WDR59 genes. b Enrichment of hsa-lncWDR59 transcripts in the RISC complex after transfection of human aortic
ECs (HAoECs) with miR-103 or control mimics together with a mutant form of Ago2, following an immunoprecipitation of GW182 protein (GW182-IP).
Results of three experiments are shown. GAPDH was used as housekeeping gene and for relative expression analysis. c Analysis of Ki67 immunostaining
and MN formation in HAoECs transfected for 48 h with hsa-lncWDR59 gapmers (hGlncWDR59). Data are normalized and expressed as percentage of the
total number of cells (n= 4 per group). d In situ hybridization for miR-103 and lncWDR59 on human plaques. Areas lacking of lesions were used as control
areas. vWF and DAPI were used to stain ECs and nuclei, respectively (n= 4 per group). e Correlation of the relative expression levels of hsa-lncWDR59 in
human carotid lesions with necrotic core area, SOX17 expression, and Ki67 endothelial staining (Ki67+vWF+), (n= 17–20 per group). *P < 0.05 by
Student’s t-test and a compute nonparametric Spearman's rho correlation analysis. Scale bar: 25 µm
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hyperlipidemia-induced EC injury and, together with the target-
ing of Klf4, promote atherosclerosis.
Previous studies indicate that endothelial Notch1 signaling
triggers endothelial differentiation38,39, promotes proliferation of
adult ECs, and prevents athero-progression6,40,41. Notably,
endothelial Dicer suppresses EC proliferation and
Notch1 signaling pathway at predilection sites of athero-
sclerosis12, and miR-103 targeting of lncWDR59 reduced EC
proliferation by inhibiting Notch1 activation. Therefore, these
ﬁndings support the hypothesis that miRNA silencing of
lncRNAs, e.g., lncWDR59 silencing by miR-103, may promote
endothelial maladaptation and atherosclerosis. Notably,
lncWDR59 promoted Notch1 activation by binding to Numb,
which mediates NICD degradation28, therefore impeding Numb
interaction with Notch1. Therefore, disturbed ﬂow promotes
Notch1 activation not only via miR-126–5p-mediated suppres-
sion of Notch1-inhibitor Dlk16, but also through lncWDR59
targeting of Notch1-inhibitor Numb. Taken together, down-
regulation of miR-126–5p and upregulation of miR-103 may both
contribute to EC maladaptation by inhibiting Notch1 activity.
Proliferating cells are vulnerable to mitotic aberrations and
DNA damage, e.g., by oxidative stress29, due to the accumulation
of damaged DNA in MN, which can lead to mitotic cata-
strophe31,32,42,43. Although MN frequency was increased in
proliferating ECs, lncWDR59 protected proliferating ECs from
micronucleic DNA damage accumulation via β-catenin signaling,
activated through Notch1-induced Sox17 expression. Accord-
ingly, β-catenin can promote cell cycle checks and DNA damage
repair processes in response to DNA damage in proliferating
cells44. Moreover, the activation of β-catenin generated a negative
feedback loop that limited Notch1 and protected ECs from
aberrant proliferation. Hence, lncWDR59 plays a dual role in EC
maladaptation by promoting EC proliferation through Notch1
activation and protecting ECs during proliferation from micro-
nucleic DNA damage accumulation through β-catenin activation.
Decreasing the effect of lncWDR59 by hyperlipidemia- and
oxLDL-mediated upregulation of miR-103 increased the vulner-
ability of proliferating ECs to mitotic aberrations, which may
limit EC regeneration and promote atherosclerosis.
Targeting of lncRNAs by miRNAs may represent a new
mechanism by which ECs are reprogrammed toward a mala-
dapted phenotype under disturbed ﬂow.
Methods
In vivo TSB treatment and staining. Following 8 weeks of HFD feeding, Apoe−/−
mice (The Jackson Laboratory, Bar Harbor, ME, USA) were randomized to the
different experimental groups and tail vein injected once weekly for four con-
secutive weeks with lncWDR59 LNA-TSB or control LNA oligonucleotides (0.5 mg
per 20 g; miRCURY LNA Target Site Blocker, in vivo use; Exiqon). During the
injection period, mice were fed with a HFD comprising 21% crude fat, 0.15%
cholesterol, and 19.5% protein. Tissues were harvested 1 week after the last
injection. Paxgene-ﬁxed/parafﬁn-embedded aortic roots were stained with Elastic
van Gieson stain. A bright-ﬁeld microscope (Leica DM6000B; Leica Microsystems)
connected to a CCD camera (Leica DFC365) was used to obtain the images. The
lesion area was quantiﬁed with ImageJ. Immunostaining of Ki67, γH2AX, C-X-C
motif chemokine ligand 1 (Cxcl1), and von Willebrand factor (vWF) was also
performed. The positive area or the number of positive cells was normalized to the
lesion area or to the total number of vWF+ cells, respectively, using ImageJ. The
analysis of the staining was performed in a blinded manner.
All animal experiments were reviewed and approved by the local authorities
(State Agency for Nature, Environment and Consumer Protection of North Rhine-
Westphalia and District Government of Upper Bavaria) in accordance with the
German animal protection laws.
RNA ﬂuorescence in situ hybridization (FISH) on human and murine tissues.
RNA FISH assay was performed using the Affymetrix protocol (ViewRNA Cell
Plus Assay, Affymetrix) with some modiﬁcations. Brieﬂy, after DNase digestion
with RNase-free DNase (Roche Diagnostics, 10776785001), tissues were incubated
with custom probe oligonucleotides speciﬁc for miR-103 and lncWDR59 designed
and synthesized by Affymetrix as Type 1 and 6, respectively, following the
manufacturer instructions. At the end of the hybridization, sections were blocked
for 1 h with 1% bovine serum albumin blocking solution, then incubated with anti-
vWF antibody.
En face immunostaining of murine tissues for micronuclei analysis. To study
MN formation and DNA damage accumulation at predilection and non-
predilection sites, aortic arches and thoracic aortas from 12-week HFD- or chow
diet-fed Apoe−/− mice were en face prepared and stained for CD31 and γH2AX.
Cell nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). The
stained tissues were visualized using a Leica DM6000B ﬂuorescent microscope. To
detect the ﬂuorescent signal in en face prepared tissues, z stacks of two-dimensional
images were recorded, and deconvolution was performed using a mathematical
algorithm to remove out-of-focus information (AF6000 3D deconvolution software
module, Leica Microsystem). The 3D rendering was performed using the LAS X 3D
algorithm module (Leica) to consider the staining and MN within CD31+ cells. For
quantiﬁcation, en face were entirely quantiﬁed. Data regarding MN formation were
expressed as number of CD31+ cells containing MN on total number of CD31+
cells, in percentage. Data regarding γH2AX immunostaining in the MN were
expressed as number of CD31+ cells showing γH2AX+ MN normalized on total
number of micronucleated CD31+ cells (previously normalized on total number of
cells), expressed in percentage. The analysis of the staining was performed in a
blinded manner.
Laser-capture microdissection. Root sections were collected on ultraviolet-
sterilized and RNase-free polyester-membrane 0.9 µm FrameSlides (Leica). ECs
and plaques were collected using a laser microdissection system (LMD7000, Leica)
in RNase-free tubes. RNA was isolated with the PAXgene RNA MinElute kit
(Qiagen) and followed by pre-ampliﬁcation and reverse transcription with Ovation
PicoSL WTA System V2 (NuGEN) following manufacturer’s instructions.
Cell culture and transfection. Primary MAoECs (passage 3; PELOBiotech GmbH,
Planneg, Germany) and primary HAoECs (passages 2, 3; Promocell, Heidelberg,
Germany) were cultured using endothelial cell complete growth medium (Pro-
mocell) containing gentamicin (0.05 mgml−1; ThermoFisher).
To grow the cells under different shear stresses, MAoECs were cultured in
collagen-coated perfusion chambers (µ-Slides VI0.4, ibidi GmbH, Martinsried,
Germany) and exposed to high shear stress (10 dyne cm−2) or low shear stress (5
dyne cm−2) for 48 h generated by the perfusion with EC complete medium (ibidi
Pump System, ibidi GmbH) containing 5-ethynyl-2’-deoxyuridine (EdU, 10 µM
ﬁnal conc., Click-iT® EdU Alexa Fluor® 488 Imaging Kit, Life Technologies) and
TSBs (TSBs in vivo ready) or control LNAs (both 50 nM ﬁnal conc., Exiqon).
MAoECs were transfected with antisense oligonucleotides to block the
interaction between miR-103 and lncWDR59 (TSB; 50 nM, miRCURY LNATM
microRNA Target Site Blockers; Exiqon) or scrambled controls. To inhibit
lncWDR59 function, murine and human ECs were transfected with lncWDR59
GapmeRs (50 nM, LNATM GapmeRs; Exiqon) that strongly induce the degradation
of the lncWDR59 transcript in the nucleus of the ECs.
MicroRNA target identiﬁcation and quantiﬁcation system (MirTrap).
MAoECs were co-transfected with miR-103-mimics, let-7b mimics, or scrambled
controls, and pMirTrap Vector using the XfectTM MicroRNA Transfection
Reagent in combination with Xfect Polymer for 24 h (all from Clontech). The
pMirTrap Vector expressed a DYKDDDDK-tagged GW182 protein, member of
the active RISC complex, which enabled locking of the miRNA/mRNA complex
into the RISC45. Cell lysates were collected and separated in two parts: one was
used as input RNA and extracted using the NucleoSpin RNA XS Kit (Macherey-
Nagel GmbH & Co. KG), the other fraction was incubated with anti-
DYKDDDDK-conjugated magnetic beads. IP and subsequent RNA isolation was
performed using the NucleoSpin RNA XS Kit. Reverse transcription of input and
IP samples were performed using a high-capacity complementary DNA (cDNA)
reverse transcription kit (Life Technologies), followed by the ampliﬁcation with
gene-speciﬁc primers (Supplementary Table 1) and SYBR Green PCR Master Mix
(Thermo Scientiﬁc). The fold enrichment was calculated according to manu-
facturer’s instructions.
Human carotid lesion samples. Human atherosclerotic lesions were collected
during carotid endarterectomy. One part was ﬁxed in 4% paraformaldehyde while
another part was immediately stored in RNAlater for RNA isolation and qPCR.
The study protocol for the collection of human atherosclerotic lesions was ﬁrst
approved from Ethics Committee of the Medical Faculty of RWTH Aachen Uni-
versity. The written informed consent was obtained from all participating patients.
Background information regarding the patients were reported in the Supplemen-
tary Table 4. Classiﬁcation of the type of the lesion was made according to the
necrotic core area using a threshold 30%46. Compute nonparametric Spearman's
rho correlation analysis was used to investigate the effect of athero-progression on
hsa-lncWDR59, SOX17, and CDKN2A expression.
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Statistical analysis. All analyses were performed in a blinded way. Power calcu-
lation with StatMate (GraphPad Software) was performed to calculate the number
of replicates needed for each experiment. The data represent the mean ± SEM and
were compared using unpaired t-test, one-way analysis of variance (ANOVA), or
two-way ANOVA (Prism, GraphPad Software), two-sided, unless stated otherwise.
A P value of <0.05 was considered signiﬁcant.
Additional methods are available in the Supplementary Information File
(see Supplementary Methods section).
Data availability. All relevant data are included in the manuscript and available
from the authors upon reasonable request. MiRNA expression proﬁle from
microarray is available online (https://doi.org/10.1038/ncomms10521) and in the
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) under
accession numbers GSE53433, GSE53435, and GSE114805.
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